Lapatinib Withdrawn Phase 1 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00513253A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib